The Blood Screening Market is expected to exceed more than US$ 3.50 Billion by 2024 at a CAGR of 9.7% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/blood-screening-market
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Grifols (Spain), Dickinson and Company (U.S.), Roche Diagnostics (Switzerland), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and Siemens Healthineers (Germany), and bioMérieux (France).Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Blood is a living tissue made up of fluid, with various cells and proteins suspended in it. It is a coursing liquid, containing red platelets, white platelets, and platelets. It gives oxygen and food to the body cells through vessels, conductors, and veins. It additionally expels metabolic waste and carbon dioxide from the body. A blood screening is a therapeutic procedure in which blood is analyzed for a particular illness or condition. It screens ailments and prevent medicinal issues and a combination of various conditions, for instance, maladies and danger. Blood screening is a medicinal procedure in which given blood is mostly tried for HIV1, HIV2, HBV, HCV, jungle fever, syphilis, and different irresistible ailments. Given blood is screened for these irresistible illnesses to lessen the danger of transfusion-transmitted contaminations (TTIs). The worldwide blood screening market comprises of different advances and items and administrations which are utilized as a part of blood donation centers and doctor’s facilities for the screening of different TTIs.
The Blood Screening Market is segmented on the lines of its product, service, technology, end user and regional. Based on product, services segmentation it covers reagents & kits, enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides, and solutions, labeling and detection reagents, immune sorbents, controls, conjugates, substrates, sample diluents and wash solutions, instruments, software and services. Based on technology segmentation it covers nucleic acid test (NAT), enzyme-linked immune sorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS). Based on end user segmentation it covers blood banks, hospitals. The Blood Screening Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The scope of the report includes a detailed study of global and regional markets on Blood Screening Market with the reasons given for variations in the growth of the industry in certain regions.
This report provides:
1) An overview of the global market for Blood Screening Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Blood Screening Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Blood Screening Market are as follows:
- Growing demand for donated blood and the donors.
- Conducting number of blood donation camps.
- Increasing safety and knowledge of donated blood.
- Economic price and acceptance of NAT for blood screening.
The restraining factors of Blood Screening Market are as follows:
- Absence of proper regulations in developing countries for the use of NAT.
- High capital investments and high maintenance cost of NAT.
- Evolution of substitute technologies.
The Blood Screening Market has been segmented as below: (Accordingly)
The Blood Screening Market Share is Segmented on the lines of Product/Services Analysis, End User Analysis, Technology Analysis and Regional Analysis. By Product/Services Analysis this market is segmented on the basis of Reagents & Kits its covers NAT Reagents & Kits. Enzymes and Polymerases, Standards and Controls, Probes and Primers, Buffers, Nucleotides, and Solutions, Labeling and Detection Reagents its covers ELISA Reagents & Kits. Immunosorbents, Controls, Conjugates, Substrates, Sample Diluents and Wash Solutions its covers Other Reagents & Kits. Instruments its covers Rental Purchase & Outright Purchase And Software and Services. By End User Analysis this market is segmented on the basis of Blood Banks sector and Hospitals sector.
By Technology Analysis this market is segmented on the basis of Nucleic Acid Test (NAT) its covers Transcription-mediated Amplification (TMA) & Real-time Polymerase Chain Reaction (PCR). Enzyme-linked Immunosorbent Assay (ELISA) its covers By Platform likes Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA) & Colorimetric Immunoassay (CI). By Generation likes First Generation, Second Generation, Third Generation & Fourth Generation & Above. Rapid Tests, Western Blot Assay and Next-generation Sequencing (NGS). By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Request Sample Report from here: https://www.marketresearchengine.com/blood-screening-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
18.104.22.168 Increasing Number of Blood Donations and Blood Donors
22.214.171.124 Increasing Demand of Donated Blood
126.96.36.199 Rising Prevalence of Infectious Diseases
188.8.131.52 Growing Affordability and Adoption of NAT for Blood Screening
184.108.40.206 Rising Awareness Regarding the Safety of Donated Blood
220.127.116.11 Capital Expenditure and Operating Costs of NAT
18.104.22.168 Lack of Regulations Mandating the Use of NAT in Developing Countries
22.214.171.124 Emergence of Alternative Technologies
126.96.36.199 Pathogen Reduction Technology
188.8.131.52 Multiplex Tests
184.108.40.206 Emerging Economies
220.127.116.11 Price Reduction
6 Blood Screening Market, By Technology
7 Blood Screening Market, By Product and Service
8 Blood Screening Market, By End User
9 Blood Screening Market, By Region
10 Competitive Landscape
11 Company Profiles
11.3 F. Hoffmann-La Roche
11.4 Abbott Laboratories
11.6 Bio-Rad Laboratories, Inc.
11.7 Siemens Healthineers (A Subsidiary of Siemens AG)
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Thermo Fisher Scientific, Inc.
11.10 Beckman Coulter (A Subsidiary of Danaher Corporation)
11.11 Becton, Dickinson and Company
Other Related Market News :
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States